Ritanserin in Treatment of Cocaine Dependence - 1

University of Pennsylvania

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Ritanserin

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000187

NIDA-00144-1

K20-00144-1

3R01DA012268 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

Enrollment: 80 patients

Sex: Male

Ages: 28 to 47 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind